Latin America Precision Oncology Market Size & Outlook

The precision oncology market in Latin America is expected to reach a projected revenue of US$ 5,358.5 million by 2030. A compound annual growth rate of 7.8% is expected of Latin America precision oncology market from 2025 to 2030.
Revenue, 2024 (US$M)
$3,423.9
Forecast, 2030 (US$M)
$5,358.5
CAGR, 2025 - 2030
7.8%
Report Coverage
Latin America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America precision oncology market, 2018-2030 (US$M)

Latin America precision oncology market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America precision oncology market highlights

  • The Latin America precision oncology market generated a revenue of USD 3,423.9 million in 2024.
  • The market is expected to grow at a CAGR of 7.8% from 2025 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating product in 2024.
  • Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.


Latin America data book summary

Market revenue in 2024USD 3,423.9 million
Market revenue in 2030USD 5,358.5 million
Growth rate7.8% (CAGR from 2025 to 2030)
Largest segmentTherapeutics
Fastest growing segmentDiagnostics
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics
Key market players worldwideThermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics


Other key industry trends

  • In terms of revenue, Latin America region accounted for 3.0% of the global precision oncology market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 50,287.5 million by 2030.

Therapeutics was the largest segment with a revenue share of 76.62% in 2024. Horizon Databook has segmented the Latin America precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


The precision oncology market in Latin America is expected to experience at a significant CAGR throughout the forecast period. The increasing investment in healthcare infrastructure and the adoption of advanced diagnostic and therapeutic technologies are major market drivers in the region.

Countries such as Brazil, and Argentina are expanding access to molecular diagnostics and targeted therapies to address the rising burden of cancer in the region. Initiatives such as public-private partnerships, regional collaborations, and government funding for cancer care are enhancing the availability of precision oncology solutions, driving market growth across Latin America.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Precision Oncology Market Companies

Name Profile # Employees HQ Website
Acrivon Therapeutics View profile 51-100 Cambridge, Massachusetts, United States, North America http://www.acrivon.com/
Relay Therapeutics View profile 251-500 Cambridge, Massachusetts, United States, North America http://relaytx.com/
BioServe View profile 51-100 Beltsville, Maryland, United States, North America https://bioserve.com
Variantyx View profile 101-250 Framingham, Massachusetts, United States, North America https://www.variantyx.com
Xilis View profile 51-100 Durham, North Carolina, United States, North America http://www.xilis.net
Strata Oncology View profile 51-100 Ann Arbor, Michigan, United States, North America http://www.strataoncology.com/
Rain Oncology View profile 101-250 Newark, California, United States, North America https://www.rainoncology.com
Invitae Corp View profile 1700 1400 16th Street, San Francisco, CA, United States, 94103 https://www.invitae.com
Exact Sciences Corp View profile 6600 5505 Endeavor Lane, Madison, WI, United States, 53719 https://www.exactsciences.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Latin America precision oncology market size, by country, 2018-2030 (US$M)

Latin America Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)

Latin America precision oncology market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online